{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:35:10Z","timestamp":1793212510193,"version":"4.5.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Facial hollowing, skin laxity, and more prominent folds are increasingly reported during weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The term \u201cOzempic face\u201d can imply a drug-specific adverse effect, although similar changes occur after other forms of substantial weight loss. This review examines the clinical evidence, proposed mechanisms, and implications for aesthetic care. PubMed, Embase, Web of Science, and Google Scholar were searched from January 2014 through August 2026. Selection was reported using PRISMA 2020 where applicable, followed by narrative synthesis. Of 958 records, 46 reports were included. Serial imaging in 20 patients showed a median 9% reduction in midfacial volume, with greater loss in superficial than deep compartments (11% vs 7%). Regression estimated approximately 7% total midfacial volume loss per 10\u2005kg lost. A FACE-Q short-form has been validated, and a survey of 1226 participants found more reports of facial volume loss and laxity with greater percentage weight loss. Post-bariatric studies also describe facial deflation and increased apparent age, particularly in older patients and after larger losses. Current evidence favors weight-loss-associated deflation superimposed on baseline anatomy and aging. The independent effect of weight-loss rate and the modifying roles of menopause and hormone therapy remain uncertain. Aesthetic treatment evidence is limited and largely uncontrolled.<\/jats:p>\n                  <jats:p>Level of Evidence: 3 (Diagnostic)<\/jats:p>\n                  <jats:p\/>","DOI":"10.1093\/asj\/sjag230","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:34:00Z","timestamp":1791891240000},"source":"Crossref","is-referenced-by-count":0,"title":["Glucagon-Like Peptide-1 Receptor Agonist-Associated Facial Changes: a Comprehensive Review of Pathophysiology, Clinical Manifestations, Risk Factors, Prevention, and Management"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0137-6849","authenticated-orcid":false,"given":"Kwang-Ho","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2026102813570272700_sjag230-B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab"},{"key":"2026102813570272700_sjag230-B2","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J Med Chem"},{"key":"2026102813570272700_sjag230-B3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"2026102813570272700_sjag230-B4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"2026102813570272700_sjag230-B5","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojaf056","article-title":"\u201cOzempic face\u201d in plastic surgery: a systematic review of the literature on GLP-1 receptor agonist-mediated weight loss and analysis of public perceptions","volume":"7","author":"Daneshgaran","year":"2025","journal-title":"Aesthet Surg J Open Forum"},{"key":"2026102813570272700_sjag230-B6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bjps.2023.04.057","article-title":"Ozempic face: a new challenge for facial plastic surgeons","volume":"81","author":"Tay","year":"2023","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2026102813570272700_sjag230-B7","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.36849\/JDD.7613","article-title":"Natural weight loss or \u201cOzempic face\u201d: demystifying a social media phenomenon","volume":"23","author":"Carboni","year":"2024","journal-title":"J Drugs Dermatol"},{"key":"2026102813570272700_sjag230-B8","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1097\/MS9.0000000000004254","article-title":"Emergence of \u201cOzempic face\u201d: addressing unintended consequences of rapid weight loss","volume":"88","author":"Jodat","year":"2026","journal-title":"Ann Med Surg (Lond)"},{"key":"2026102813570272700_sjag230-B9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40200-025-01778-3","article-title":"Facial aging after GLP-1 receptor agonist-induced weight loss: the emerging Ozempic face phenomenon","volume":"24","author":"K\u0131l\u0131\u00e7","year":"2025","journal-title":"J Diabetes Metab Disord"},{"key":"2026102813570272700_sjag230-B10","doi-asserted-by":"publisher","DOI":"10.1002\/der2.70003","article-title":"Semaglutide \u201cOzempic\u201d face and implications in cosmetic dermatology","volume":"5","author":"Montecinos","year":"2024","journal-title":"Dermatol Rev"},{"key":"2026102813570272700_sjag230-B11","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics12050221","article-title":"Cosmetic considerations of semaglutide","volume":"12","author":"Baggett","year":"2025","journal-title":"Cosmetics"},{"key":"2026102813570272700_sjag230-B12","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojag080","article-title":"Response by Sharp to \u201cOzempic Face: Construct, Consequence, or Clinical Entity?\u201d by Daneshgaran et\u00a0al","volume":"8","author":"Sharp","year":"2026","journal-title":"Aesthet Surg J Open Forum"},{"key":"2026102813570272700_sjag230-B13","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojae069","article-title":"Soft tissue facial changes following massive weight loss secondary to medical and surgical bariatric interventions: a systematic review","volume":"6","author":"Jafar","year":"2024","journal-title":"Aesthet Surg J Open Forum"},{"key":"2026102813570272700_sjag230-B14","doi-asserted-by":"publisher","first-page":"481e","DOI":"10.1097\/PRS.0000000000004738","article-title":"Influence of massive weight loss on the perception of facial age: the Facial Age Perceptions Cohort","volume":"142","author":"Valente","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"2026102813570272700_sjag230-B15","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70670","article-title":"Rising public interest in weight loss medications and growing awareness of their aesthetic sequelae: an infodemiologic Google Trends analysis and clinical diagnostic patterning","volume":"25","author":"McCarthy","year":"2026","journal-title":"J Cosmet Dermatol"},{"key":"2026102813570272700_sjag230-B16","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000007282","article-title":"Interest in facial volume restorative procedures with the rise in \u201cOzempic face\u201d: a Google Trends analysis","volume":"13","author":"Mnajjed","year":"2025","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2026102813570272700_sjag230-B17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bjps.2024.07.051","article-title":"The rise of \u201cOzempic face\u201d: analyzing trends and treatment challenges associated with rapid facial weight loss induced by GLP-1 agonists","volume":"96","author":"Mansour","year":"2024","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2026102813570272700_sjag230-B18","doi-asserted-by":"publisher","first-page":"NP809","DOI":"10.1093\/asj\/sjae132","article-title":"Decoding the implications of glucagon-like peptide-1 receptor agonists on accelerated facial and skin aging","volume":"44","author":"Ridha","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2026102813570272700_sjag230-B19","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s12020-025-04293-w","article-title":"GLP-1RA and the possible skin aging","volume":"89","author":"Paschou","year":"2025","journal-title":"Endocrine"},{"key":"2026102813570272700_sjag230-B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026102813570272700_sjag230-B21","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjag095","article-title":"Measuring facial appearance in the era of GLP-1 receptor agonist use with the FACE-Q Aesthetics item library","author":"Klassen","year":"2026","journal-title":"Aesthet Surg J"},{"key":"2026102813570272700_sjag230-B22","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1007\/s13555-026-01882-z","article-title":"Skin impacts and tradeoffs of GLP-1 therapy: improved patient-reported outcomes of inflammatory skin disease in the era of \u201cOzempic face\u201d","volume":"16","author":"Rao","year":"2026","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026102813570272700_sjag230-B23","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.71145","article-title":"Dermatological, trichological and quality of life consequences of GLP-1 receptor agonist-mediated weight loss: a US cross-sectional survey","volume":"25","author":"Olivero","year":"2026","journal-title":"J Cosmet Dermatol"},{"key":"2026102813570272700_sjag230-B24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14248792","article-title":"Functional and aesthetic periorbital, ocular adnexal and ocular surface changes linked to GLP-1 receptor agonists","volume":"14","author":"Kapantais","year":"2025","journal-title":"J Clin Med"},{"key":"2026102813570272700_sjag230-B25","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1007\/s00266-026-05820-4","article-title":"Effects of GLP-1 receptor agonists on skin quality: a comprehensive literature review","volume":"50","author":"Barone","year":"2026","journal-title":"Aesthetic Plast Surg"},{"key":"2026102813570272700_sjag230-B26","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13050127","article-title":"A closer look at the dermatological profile of GLP-1 agonists","volume":"13","author":"Persson","year":"2025","journal-title":"Diseases"},{"key":"2026102813570272700_sjag230-B27","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1007\/s13555-025-01537-5","article-title":"Benefit-risk assessment of GLP-1 receptor agonists: implications for dermatologists and plastic surgeons","volume":"15","author":"Cedirian","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026102813570272700_sjag230-B28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ohn.1209","article-title":"Radiographic midfacial volume changes in patients on GLP-1 agonists","volume":"173","author":"Sharma","year":"2025","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2026102813570272700_sjag230-B29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jcms.2020.05.010","article-title":"Morphological changes of the human face after massive weight-loss due to bariatric surgery","volume":"48","author":"Peters","year":"2020","journal-title":"J Craniomaxillofac Surg"},{"key":"2026102813570272700_sjag230-B30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s11695-024-07066-y","article-title":"Comparison of histological skin changes after massive weight loss in post-bariatric and non-bariatric patients","volume":"34","author":"Hany","year":"2024","journal-title":"Obes Surg"},{"key":"2026102813570272700_sjag230-B31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/IOP.0000000000003070","article-title":"Effects of glucagon-like peptide-1 receptor agonist on facial landmarks","volume":"42","author":"Chen","year":"2026","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2026102813570272700_sjag230-B32","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1007\/s00266-026-06002-y","article-title":"Psychosocial outcomes and aesthetic expectations in female patients undergoing body contouring after GLP-1\u2013induced weight loss: a prospective pilot comparative study with post-bariatric patients","volume":"50","author":"Ponzo","year":"2026","journal-title":"Aesthetic Plast Surg"},{"key":"2026102813570272700_sjag230-B33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3945\/an.116.014506","article-title":"Preserving healthy muscle during weight loss","volume":"8","author":"Cava","year":"2017","journal-title":"Adv Nutr"},{"key":"2026102813570272700_sjag230-B34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/oby.24336","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society","volume":"33","author":"Mozaffarian","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"2026102813570272700_sjag230-B35","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/DSS.0000000000005175","article-title":"Cutaneous variations in stem-cell population in those on GLP1-receptor agonists: a comparative controlled study","volume":"52","author":"Firsowicz","year":"2026","journal-title":"Dermatol Surg"},{"key":"2026102813570272700_sjag230-B36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1159\/000544023","article-title":"Dermatologic implications of glucagon-like peptide-1 receptor agonist medications","volume":"11","author":"Burke","year":"2025","journal-title":"Skin Appendage Disord"},{"key":"2026102813570272700_sjag230-B37","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41586-026-10330-z","article-title":"Genetic predictors of GLP1 receptor agonist weight loss and side effects","volume":"653","author":"Su","year":"2026","journal-title":"Nature"},{"key":"2026102813570272700_sjag230-B38","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1097\/DSS.0000000000005180","article-title":"GLP-1-induced weight loss and the face: anatomical mechanisms and rationale for collagen-stimulating and volumizing aesthetic treatments","volume":"52","author":"Frank","year":"2026","journal-title":"Dermatol Surg"},{"key":"2026102813570272700_sjag230-B39","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"2026102813570272700_sjag230-B40","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70094","article-title":"Consensus statements on managing aesthetic needs in prescription medication-driven weight loss patients: an international, multidisciplinary Delphi study","volume":"24","author":"Nikolis","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"2026102813570272700_sjag230-B41","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1136\/bmj.287.6402.1337","article-title":"Sex hormones and skin collagen content in postmenopausal women","volume":"287","author":"Brincat","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2026102813570272700_sjag230-B42","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0002-9378(94)70242-X","article-title":"A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness","volume":"170","author":"Maheux","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"2026102813570272700_sjag230-B43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0020-7292(99)00166-6","article-title":"The effects of systemic hormonal replacement therapy on the skin of postmenopausal women","volume":"68","author":"Sauerbronn","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"2026102813570272700_sjag230-B44","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/13697130701444073","article-title":"A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women","volume":"10","author":"Sator","year":"2007","journal-title":"Climacteric"},{"key":"2026102813570272700_sjag230-B45","doi-asserted-by":"publisher","first-page":"e576","DOI":"10.1111\/jdv.18071","article-title":"Influence of menopause and hormone replacement therapy on epidermal ageing and skin biomechanical function","volume":"36","author":"Mellody","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026102813570272700_sjag230-B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26095-0","article-title":"Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy","volume":"12","author":"Kendall","year":"2022","journal-title":"Sci Rep"},{"key":"2026102813570272700_sjag230-B47","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/archderm.144.9.1129","article-title":"Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo","volume":"144","author":"Ritti\u00e9","year":"2008","journal-title":"Arch Dermatol"},{"key":"2026102813570272700_sjag230-B48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jaad.2008.05.009","article-title":"Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women","volume":"59","author":"Phillips","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2026102813570272700_sjag230-B49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.6118\/jmm.22042","article-title":"Skin rejuvenation in women using menopausal hormone therapy: a systematic review and meta-analysis","volume":"29","author":"Pivazyan","year":"2023","journal-title":"J Menopausal Med"},{"key":"2026102813570272700_sjag230-B50","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70393","article-title":"Managing menopausal skin changes: a narrative review of skin quality changes, their aesthetic impact, and the actual role of hormone replacement therapy in improvement","volume":"24","author":"Viscomi","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"2026102813570272700_sjag230-B51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/jocd.12490","article-title":"The science behind skin care: moisturizers","volume":"17","author":"Draelos","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"2026102813570272700_sjag230-B52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/2229-5178.110593","article-title":"Vitamin C in dermatology","volume":"4","author":"Telang","year":"2013","journal-title":"Indian Dermatol Online J"},{"key":"2026102813570272700_sjag230-B53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1529-8019.2009.01289.x","article-title":"Photoprotection: a review of the current and future technologies","volume":"23","author":"Wang","year":"2010","journal-title":"Dermatol Ther"},{"key":"2026102813570272700_sjag230-B54","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70681","article-title":"Topical volumizing cream improves facial volume and skin health in adults with rapid weight loss from pharmacologic (GLP-1\/GIP agonists), surgical, or behavioral interventions","volume":"25","author":"Nguyen","year":"2026","journal-title":"J Cosmet Dermatol"},{"key":"2026102813570272700_sjag230-B55","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s13555-026-01699-w","article-title":"Clinical efficacy of a flavo-proxylane topical regimen pre- and post-ultrasound procedure for subjects undergoing glucagon-like peptide 1 (GLP-1) receptor agonist therapy","volume":"16","author":"Moradi","year":"2026","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026102813570272700_sjag230-B56","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojaf030","article-title":"A single-center, blinded, placebo-controlled study evaluating cosmetic efficacy and safety of a novel topical GLPSGLT in glucagon-like peptide-1 analog-treated patients","volume":"7","author":"Semersky","year":"2025","journal-title":"Aesthet Surg J Open Forum"},{"key":"2026102813570272700_sjag230-B57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1468-2494.2009.00490.x","article-title":"Role of topical peptides in preventing or treating aged skin","volume":"31","author":"Gorouhi","year":"2009","journal-title":"Int J Cosmet Sci"},{"key":"2026102813570272700_sjag230-B58","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojag011","article-title":"Nonsurgical aesthetic treatment of the face and neck in GLP-1 receptor agonist weight loss patients: experience-based considerations","volume":"8","author":"Moradi","year":"2026","journal-title":"Aesthet Surg J Open Forum"},{"key":"2026102813570272700_sjag230-B59","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.1007\/s00266-026-05953-6","article-title":"Preventing GLP-1-associated facial aging: an anatomy-driven risk stratification model and prevention algorithm in the \u201cOzempic face\u201d era","volume":"50","author":"Castrellon","year":"2026","journal-title":"Aesthetic Plast Surg"},{"key":"2026102813570272700_sjag230-B60","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16716","article-title":"The role of GLP-1 agonists in esthetic medicine: exploring the impact of semaglutide on body contouring and skin health","volume":"24","author":"Haykal","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"2026102813570272700_sjag230-B61","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/DSS.0000000000005166","article-title":"Aesthetic concerns and nonsurgical treatment trends in patients with GLP-1 agonist-associated weight loss","volume":"52","author":"Fabi","year":"2026","journal-title":"Dermatol Surg"},{"key":"2026102813570272700_sjag230-B62","doi-asserted-by":"publisher","DOI":"10.3390\/dermato6030029","article-title":"Dermatologic consequences of Ozempic-induced weight loss: a review of facial aging, aesthetic implications, and treatment","volume":"6","author":"Chugh","year":"2026","journal-title":"Dermato"},{"key":"2026102813570272700_sjag230-B63","doi-asserted-by":"publisher","DOI":"10.25259\/CSDM_97_2025","article-title":"Semaglutide and the skin: a brief review of dermatologic implications","volume":"5","author":"Salam","year":"2025","journal-title":"CosmoDerma"},{"key":"2026102813570272700_sjag230-B64","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/asj\/sjaf240","article-title":"A multicenter, open-label study of combined poly-L-lactic acid and hyaluronic midface filler regimen enhances facial harmony and skin quality in GLP-1 medication users","volume":"46","author":"Lorenc","year":"2026","journal-title":"Aesthet Surg J"},{"key":"2026102813570272700_sjag230-B65","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S620566","article-title":"Aesthetic use of poly-L-lactic acid and hyaluronic acid fillers in medication-driven weight loss due to GLP-1 receptor agonists: real-world case series from Latin America","volume":"19","author":"Avelar","year":"2026","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026102813570272700_sjag230-B66","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojaf088","article-title":"Hyperdilute Radiesse preserves facial volume in glucagon-like peptide-1 receptor agonist users undergoing rapid weight loss","volume":"7","author":"Durairaj","year":"2025","journal-title":"Aesthet Surg J Open Forum"},{"key":"2026102813570272700_sjag230-B67","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14155269","article-title":"\u201cOzempic face\u201d: an emerging drug-related aesthetic concern and its treatment with endotissutal bipolar radiofrequency (RF)\u2014our experience","volume":"14","author":"Catalfamo","year":"2025","journal-title":"J Clin Med"},{"key":"2026102813570272700_sjag230-B68","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s11695-022-06363-8","article-title":"Changes of facial features after bariatric surgery: a systematic review","volume":"33","author":"Wong","year":"2023","journal-title":"Obes Surg"},{"key":"2026102813570272700_sjag230-B69","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.53323","article-title":"Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists","volume":"9","author":"Wang","year":"2026","journal-title":"JAMA Netw Open"},{"key":"2026102813570272700_sjag230-B70","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00266-021-02649-x","article-title":"M1 polarized macrophages persist in skin of post-bariatric patients after 2 years","volume":"46","author":"Amaral","year":"2022","journal-title":"Aesthetic Plast Surg"},{"key":"2026102813570272700_sjag230-B71","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.anplas.2016.09.008","article-title":"Quantitative analysis of midface fat compartments mass with ageing and body mass index, anatomical study","volume":"61","author":"Mertens","year":"2016","journal-title":"Ann Chir Plast Esthet"}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjag230\/71930285\/sjag230.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjag230\/71930285\/sjag230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:57:11Z","timestamp":1793210231000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/advance-article\/doi\/10.1093\/asj\/sjag230\/8915969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1093\/asj\/sjag230","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"article-number":"sjag230"}}